Skip to main content
. Author manuscript; available in PMC: 2014 Jun 28.
Published in final edited form as: Neurosci Lett. 2013 May 10;547:16–20. doi: 10.1016/j.neulet.2013.04.056

Fig 2. RNF11 and activated NF-κB in PD.

Fig 2

Cortical sections from brains of control (left panel) and PD (right panel) cases were immunolabeled with RNF11 (top) and phospho-p65 (bottom, a marker of activated NF-κB). Representative photomicrographs demonstrate that reduced RNF11-immunoreactivity (ir) is associated with increased phospho-p65-ir in PD in comparison to control cases. Scale bar − 50 µm.